3-[3-(2,2-dimethyl-[1,3]dioxolan-4-ylmethyl)-4-methoxyphenyl]propyn-1-ol 在
钯氢气 、 钯 作用下,
以
乙酸乙酯 为溶剂,
反应 16.0h,
以to give 0.48 g of the title compound的产率得到3-[3-(2,2-dimethyl-[1,3]dioxolan-4-ylmethyl)-4-methoxyphenyl]propan-1-ol
The present invention provides a compound represented by the formula (1) or a pharmacologically acceptable salt thereof, or a hydrate thereof (provided that a compound in which all of R4a, R4b, and R4c are hydrogen atoms is excluded.):
[wherein R1 represents a hydrogen atom, R2 represents a hydrogen atom, R3 represents the formula:
wherein R4a, R4b, and R4c are the same as or different from each other and each represents a hydrogen atom, a C1-6 alkyl group or a C1-6 alkoxy group, etc.]